Fatigue and cognitive impairment are 2 of the most common health problems associated with multiple sclerosis (MS). Recent MS studies evaluate the nature of these 2 conditions not just as side effects of MS, but as chronic conditions with varying degrees of severity based on objective assessment and self-perception.
Fatigue and cognitive impairment are 2 of the most common health problems associated with multiple sclerosis (MS). Recent MS studies evaluate the nature of these 2 conditions not just as side effects of MS, but as chronic conditions with varying degrees of severity based on objective assessment and self-perception. At the 29th Annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis, 2 posters presented the findings of observational studies which explored fatigue and cognition in MS. In the first poster discussed here, Joan Thelen, University of Missouri, Kansas City, presents the effects of polypharmacy on fatigue and self-reported cognition in MS patients. In the second, Matteo Pardini, MD, Department of Neurosciences, University of Genoa, Italy, presents a study on the seemingly paradoxical relationship between persistent subjective fatigue and task-related performance in MS.
In her poster, Thelen investigates the relationship between polypharmacy, fatigue, and cognition in MS. For this observational study, 86 patients provided their current list of medications and completed 8 questionnaires, half of which were self-evaluations, and the other half objective neuropsychological tests. Scores were compared to MS patients without polypharmacy treatment, and healthy controls.
The 4 self-report measures indicated a significant difference in fatigue levels and cognitive ability between MS patients with polypharmacy and the other 2 groups. MS patients with polypharmacy treatments reported more fatigue, processing speed difficulties, and memory problems than MS patients without polypharmacy. Furthermore, a mutlivariate analysis of covariance (MANCOVA) revealed that polypharmacy status had a significant effect on MS patients’ self-report measures, an important factor to consider when looking at comparisons of the 4 objective assessments where the only considerable difference between identified polypharmacy patients and non-polypharmacy patients was in cognition.
Dr Pardini’s study, on the other hand, ascribes significance to fatigue perception, particularly in its relationship with MS. Pardini’s poster presents findings for an observational study which evaluated the relationship between persistent subjective fatigue and task performance in relapsing-remitting MS patients (RRMS). The study examined both motor behavioral and neuroanatomical levels through a task-related exercise and MRI.
To carry out their study, Pardini and his team recruited 14 RRMS with minimal disability (EDSS ≤ 2). Before beginning the exercise, a patient’s fatigue perception was evaluated with the Modified Fatigue Impact Scale (MFIS), a quantitative, self-report questionnaire. The patient’s temporal accuracy (TA) was then measured by a rhythm exercise whereby the patient attempted to maintain a consistent tempo with a metronome using a finger-to-thumb motion. Temporal accuracy was assessed with concurrent MRI through the use of an MR-compatible engineered glove.
As a scatter plot on the poster demonstrates, motor behavioral exercise results indicated a positive relationship between MFIS score and TA, as increased persistent subjective fatigue was associated with higher temporal accuracy. This reveals a potential “paradox” in the relationship between fatigue perception and task performance.
Neuroanatomical results were equally as significant. Functional MRI data (fMRI), with TA as a covariate, showed that “only the right cerebellar hemisphere positively correlated with increasing TA.” Further, with MFIS score as a covariate, fMRI indicated that MFIS score had a positive relationship with the left orbitofrontal cortex (OFC) and the right cerebellum. In summary, then, the neuroanatomical study showed that MFIS-related OFC activation positively correlated with TA-related cerebellar activation.
Dr Pardini furthers the discussion by noting that the OFC is functionally-related to sensorimotor processing, motivation, and self-evaluation, all important factors in persistent subjective fatigue. The observed association between neurology and behavior, as Pardini puts it, “point to a possible adaptive role for fatigue as the subjective correlate of increased resource demand for motor activities.”
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Oncology Onward: A Conversation With Dr Shereef Elnahal, Under Secretary for Health
April 20th 2023Shereef Elnahal, MD, MBA, under secretary for health at the Veterans Health Administration (VHA), sat for a conversation with our hosts Emeline Aviki, MD, MBA, Memorial Sloan Kettering Cancer Center, and Stephen Schleicher, MD, MBA, Tennessee Oncology, that covered the cancer footprint of the VHA.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More